Product information

From Health Canada

No match found

No other product was found with the same active ingredient group.

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2020-05-19

Original market date: See footnote 1

2011-09-19

Product name:

NEO-TERRAMYCIN 50/50

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02325098

Product Monograph/Veterinary Labelling:

Date: 2020-05-19 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

PHIBRO ANIMAL HEALTH CORPORATION
Glenpoint Centre East, 3rd Floor, 300 Frank W Burr Blvd., Ste. 21
Teaneck
New Jersey
United States 07666

Class:

Veterinary

Species:

Swine (pigs)

Dosage form(s):

Drug Premix

Route(s) of administration:

Oral

Number of active ingredient(s):

2

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

Anatomical Therapeutic Chemical (ATC): See footnote 4

Not Applicable

Active ingredient group (AIG) number:See footnote5

0205556003

List of active ingredient(s)
Active ingredient(s) Strength
NEOMYCIN SULFATE 110 G / Kg
OXYTETRACYCLINE HYDROCHLORIDE 110 G / Kg
Version 4.0.2
Date modified: